EUVIMEDSkopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Natural Glycosides in Neurodegenerative Diseases: Multi‐Target Mechanisms via the Gut–Brain Axis

Lu Chen, Mengzhen Wei, Qiong Zhang, Lei Jia, Zhihong Zheng, Rui Tan iD

Phytotherapy Research · 2026-11-11

DOI: 10.1002/ptr.70521 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, published online on 2026-11-11. Written by Lu Chen and 5 co-authors. Institution: College of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China. 159 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Sichuan Provincial Administration of Traditional Chinese Medicine.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The multifactorial complexity of neurodegenerative diseases (NDs), including Alzheimer's and Parkinson's disease, limits the efficacy of single‐target therapies. Natural glycosides exhibit promising neuroprotective potential, but their clinical translation is hindered by poor oral bioavailability and limited blood–brain barrier (BBB) penetration. The gut–brain axis offers a framework for understanding their potential biological effects beyond direct central exposure. This review explores the multi‐target mechanisms of natural glycosides in NDs, focusing on their interactions with the gut–brain axis. A narrative literature search was conducted in PubMed, Web of Science, and ScienceDirect for studies published up to June 2026. Relevant literature on glycosides, NDs, gut microbiota, microbial biotransformation, pharmacokinetics, and neuroprotective mechanisms was critically reviewed. Natural glycosides may affect ND‐related processes through gut‐mediated and systemic/central mechanisms. Poorly absorbed glycosides can interact with intestinal microbiota, potentially modulating microbial composition, intestinal barrier integrity, and short‐chain fatty acids (SCFAs) production. Microbial biotransformation may generate metabolites with altered physicochemical properties and systemic exposure, potentially enhancing central nervous system accessibility in a compound‐specific manner. Experimental evidence also suggests effects on neuroinflammation, mitochondrial homeostasis, autophagy, and synaptic function. However, most findings remain preclinical, with limited direct human evidence. The gut–brain axis provides a valuable perspective for understanding the biological activities of natural glycosides despite their limited oral bioavailability and BBB penetration. Further pharmacokinetic studies, causal investigations of microbiota‐mediated effects, and controlled clinical trials are needed to establish their therapeutic potential in NDs.

Subjects

Author keywords

Alzheimer's diseaseParkinson's diseaseglycosidesgut–brain axisneurodegenerative diseases

Authors and institutions

  • College of Life Science and Engineering, Southwest Jiaotong University, Chengdu, China.
  • College of Materials Science and Engineering, Southwest Jiaotong University, Chengdu, China.
  • College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

ORCID profiles: Rui Tan

Funding

  • Sichuan Provincial Administration of Traditional Chinese Medicine

Cite

APA

Chen, L., Wei, M., Zhang, Q., Jia, L., Zheng, Z., & Tan, R. (2026). Natural Glycosides in Neurodegenerative Diseases: Multi‐Target Mechanisms via the Gut–Brain Axis. Phytotherapy Research. https://doi.org/10.1002/ptr.70521

Vancouver

Chen L, Wei M, Zhang Q, Jia L, Zheng Z, Tan R. Natural Glycosides in Neurodegenerative Diseases: Multi‐Target Mechanisms via the Gut–Brain Axis. Phytotherapy Research. 2026. doi:10.1002/ptr.70521

BibTeX
@article{Chen2026,
  author = {Chen, Lu and Wei, Mengzhen and Zhang, Qiong and Jia, Lei and Zheng, Zhihong and Tan, Rui},
  title = {Natural Glycosides in Neurodegenerative Diseases: Multi‐Target Mechanisms via the Gut–Brain Axis},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70521}
}
Start for free →